Form QUALIF PK Kirk Inc.

    X0101

    QUALIF

    33

    LIVE

    
        2021-05-12
        16:00:00
        
1-A
        
            0001833372
            PK Kirk Inc.
            024-11436
        
    

You May Also Be Interested In

• Abzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for De-Risking the Development of Complex Biologics and Bioconjugates
• BioNJ Announces Lineup for BioPartnering Conference
• FERRILLI NAMED ELLUCIAN IMPLEMENTATION PARTNER OF THE YEAR FOR SECOND CONSECUTIVE YEAR